Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in μ-opioid receptor knockout mice

被引:34
|
作者
Yoo, JH
Lee, SY
Loh, HH
Ho, IK
Jang, CG [1 ]
机构
[1] Sungkyunkwan Univ, Coll Pharm, Dept Pharmacol, Suwon 440746, South Korea
[2] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
[3] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA
关键词
mu-opioid receptor knockout mice; novelty; emergence; anxiety; emotion; M-1 muscarinic receptor; 5-HT1A receptor; autoradiography; in situ hybridization;
D O I
10.1002/syn.20067
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Anxiety and depression alterations have been reported in mu-opioid receptor knockout mice after exon 2 disruption. However, emotional behaviors, such as novelty and emergence responses have not been reported in mu-opioid receptor knockout mice due to the disruptions of exon 2 and 3. Here, we report that mu-opioid receptor knockout mice, with deletion of exon 2 and 3, display significant emotional behavior changes; they showed less anxiety in the elevated plus maze and emergence tests, reduced response to novel stimuli in the novelty test, and less depressive-like behavior in the forced-swim test. Analysis of the compensatory mechanism in mu-opioid receptor knockout mice revealed that the M-1 mRNA levels were reduced in the cortex, caudate putamen, nucleus accumbens, and hippocampus, and that M-1 receptor levels were reduced in the nucleus accumbens, CA1, and the dentate gyrus of the hippocampus, versus the wild-type. However, 5-HT1A receptor levels were significantly elevated in the cerebral cortex and in the hypothalamus of mu-opioid receptor knockout mice versus the wild-type. These aberrant emotional behavioral phenotypes are possibly related to M-1 and 5-HT1A receptor alterations in the mu-opioid receptor knockout mice. Overall, our study suggests that mu-opioid receptor may play a role in the modification of emotional responses to novelty, anxiety, and depression.
引用
收藏
页码:72 / 82
页数:11
相关论文
共 50 条
  • [41] Pituitary-adrenal responses to oxotremorine and acute stress in male and female M1 muscarinic receptor knockout mice:: Comparisons to M2 muscarinic receptor knockout mice
    Rhodes, M. E.
    Rubin, R. T.
    McKlveen, J. M.
    Karwoski, T. E.
    Fulton, B. A.
    Czambel, R. K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 (05) : 617 - 625
  • [42] Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice
    Woolley, Marie L.
    Carter, Helen J.
    Gartlon, Jane E.
    Watson, Jeanette M.
    Dawson, Lee A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 603 (1-3) : 147 - 149
  • [43] Recombinant expression of a selective blocker of M1 muscarinic receptors
    Näsman, J
    Jolkkonen, M
    Ammoun, S
    Karlsson, E
    Åkerman, KEO
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (02) : 435 - 439
  • [44] Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia
    Scarr, Elizabeth
    Sundrarn, Suresh
    Keriakous, Dahlia
    Dean, Brian
    BIOLOGICAL PSYCHIATRY, 2007, 61 (10) : 1161 - 1170
  • [45] Is the 5-HT1A receptor knockout mouse an animal model of anxiety?
    Olivier, B
    Pattij, T
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 708 - 709
  • [46] 5-HT1A receptor knockout mouse as a genetic model of anxiety
    Toth, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 463 (1-3) : 177 - 184
  • [47] Constitutive and inducible knockout of the 5-HT1A receptor:: Behavioural consequences
    Ramboz, S
    Oosting, D
    Hen, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : U155 - U155
  • [48] Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine
    Limon-Morales, Ofelia
    Soria-Fregozo, Cesar
    Arteaga-Silva, Marcela
    Vazquez-Palacios, Gonzalo
    Bonilla-Jaime, Herlinda
    PHYSIOLOGY & BEHAVIOR, 2014, 124 : 37 - 44
  • [49] 5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice
    Christelle Monaca
    Benjamin Boutrel
    René Hen
    Michel Hamon
    Joëlle Adrien
    Neuropsychopharmacology, 2003, 28 : 850 - 856
  • [50] 5-HT1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep:: Studies in 5-HT1A and 5-HT1B knockout mice
    Monaca, C
    Boutrel, B
    Hen, R
    Hamon, M
    Adrien, J
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (05) : 850 - 856